Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Shire Plays Up Xiidra Launch, Downplays Missed Sales Expectations

Executive Summary

Launched in August for dry eye disease, Xiidra already has seen nearly 65,000 prescriptions written and has captured 16% market share in the US. Overall quarterly sales came in below Wall Street expectations for Shire, but the firm says it was a strong quarter of execution.

Advertisement

Related Content

Shire Touts Ongoing Xiidra Growth, Targets Increased Medicare Access
Shire May Spin Out Neuroscience Unit To Tighten Rare Disease Focus
Shire's Ornskov On Goals And Accomplishments One Year After Baxalta Merger
Shire’s Sales, R&D Heads Shed Light On The Post-Baxalta Road Ahead
4Q Pharma Results Preview, Part 3: Gilead, GSK, Sanofi, Allergan, Shire, Bayer, Valeant
J.P. Morgan Notebook Day 2: Bristol Humbled By Competition, Sanofi’s Sarilumab Ready For Review, Justifying Spinraza’s Price And More
J.P. Morgan Notebook Day 2: Bristol Humbled By Competition, Sanofi’s Sarilumab Ready For Review, Justifying Spinraza’s Price And More
Shire Builds Confidence In $20bn Revenue Target
Stockwatch: Has Sentiment Left the Biopharma Sector?
Allergan’s Namesake Acquisition Looks Well-Timed As Established Brands Falter

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC097589

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel